Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Leckrone worried about a capital call by PDS?

From the TPL Chap 11 Plan:

TPL is to make quarterly payments to the Creditors Trust Trustee

i. 12% of Adjusted Gross Revenues (I believe this is after attorney fees are paid) until Classes 1-6 are paid in full

TPL shall transmit quarterly payments for deposit provided, however, that in any quarter in which the transmittal of the quarterly payment to the Creditor Trust Trustee would result in a reduction of the WCR (working Capital Reserve) the quarterly payment for that quarter shall be reduced accordingly...such reduction shall not be a PLan Default as long as TPL has transmitted an amount equal to 12% of AGR annually

Leckrone will resign from PDS Management Committee. ....if the PDS Management committe demands that TPL fund PDS then Mr. Leckrone's seat on the PDS Management committee shall immediately revert to him or his heir, successor or assign with the authority to approve any 3rd member of such committee as may be permitted by law

Share
New Message
Please login to post a reply